Salipro Biotech to Join the JETRO Healthcare Business Invitation Program in Japan

Salipro Biotech is honored to be selected for the Chiba & Ibaraki Healthcare Business Invitation Program 2025, organized by JETRO.

From October 7–9, our BD Manager, Lorena, will be engaging with leading Japanese research institutions, innovation hubs, and companies in Ibaraki, Chiba, and Kanagawa, including participation in Bio Japan 2025.

With ongoing collaborations in Japan, we are excited to further strengthen our relations and explore new opportunities where the Salipro® platform can enable Japanese pharma and biotech companies in advancing their drug discovery programs towards challenging membrane proteins.

We look forward to this excellent opportunity to connect with potential local collaboration partners and gain insights into the Japanese life science innovation ecosystem!